Catalyst Wire Dossier Catalyst Wire Dossier

Zevalin

ibritumomab tiuxetan
Drug timelines are a Plus or Pro feature.

73 regulatory and trial events tracked for Zevalin, covering 2006-09-12 to 2025-09-30. Get the full timeline:

Most recent: Clinical Trial Update: Combination Chemotherapy, Rituximab, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Newly Diagnosed Large B-Cell Lymphoma [Phase 2]

See pricing